Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Completed 2Terminated 1

Sponsor Class

NIH 2

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 1

Conditions

Acquired Immunodeficiency Syndrome 12HIV Infections 11Sarcoma, Kaposi 9Lymphoma 5Lymphoma, Non-Hodgkin 2AIDS-Related Opportunistic Infections 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Multi-centric Castleman's Disease 1Leukemia-Lymphoma, Adult T-Cell 1Herpesviridae Infections 1Epstein-Barr Virus Infections 1Dendritic Cell Sarcoma, Interdigitating 1Cytomegalovirus Infections 1Castleman Disease 1AIDS-Related Complex 1

Interventions

Zidovudine 2Acyclovir 2Nelfinavir 1Dapsone 1Cidofovir 1Alitretinoin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × AIDS-Related Opportunistic Infections × Zidovudine × Clear all
NCT00000712 2021-11-04

A Multicenter, Double Blind, Comparative Study of Zidovudine Alone Versus Zidovudine and Acyclovir as Treatment for HIV-Infected Patients With CD4+ Counts Less Than 200 Cells/mm3

National Institute of Allergy and Infectious Diseases (NIAID)

Phase 2 Completed
400 enrolled

Acquired Immunodeficiency Syndrome, Cytomegalovirus Infections, Herpesviridae Infections, HIV Infections, AIDS-Related Opportunistic Infections, Epstein-Barr Virus Infections

NCT00000994 2021-11-04

A Study of AZT in HIV-Infected Patients With AIDS-Related Kaposi's Sarcoma

National Institute of Allergy and Infectious Diseases (NIAID)

Phase 3 Completed
240 enrolled
Sarcoma

Acquired Immunodeficiency Syndrome, Sarcoma, Kaposi, HIV Infections, AIDS-Related Opportunistic Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡